International College of Neuropsychopharmacology (CINP), 2024
Global annual congress offering a platform for learning about the latest research advances and new treatments in neuropharmacology, psychiatry, and neuroscience.
U.S. Medical
This site is intended for U.S. Healthcare Professionals.
To report an adverse event or product quality complaint, call 1-877-TAKEDA-7 (1-877-825-3327)
Select "Upcoming" to see a list of future scientific congresses in neuroscience. Select "Past" to review data and presentations from recent congresses. This is not intended to be a comprehensive resource of all congresses and congress materials across therapeutic and disease areas.
Congress materials may include information about investigational use(s) of compounds/products that are not approved for use by the U.S. Food and Drug Administration (FDA) and/or are inconsistent with the Prescribing Information. Takeda does not recommend the use of any Takeda product beyond the approved labeling. Any decisions regarding the usage of a Takeda product beyond the approved labeling is left to the discretion of the healthcare professional. Takeda makes no representations about whether investigational compounds or unapproved uses will be approved by the FDA.
Global annual congress offering a platform for learning about the latest research advances and new treatments in neuropharmacology, psychiatry, and neuroscience.
Annual meeting bringing perspectives together from academia, NIH, FDA, clinicians and industry on key aspects of neuropsychiatric drug development, pharmacogenetics and personalized interventions.
Leading global conference discussing how to establish, incentivize, and share value sustainable for health systems, patients, and technology developers.
Annual meeting attracting the largest audience of psychiatrists and other mental health professionals offering opportunities to learn the latest in effective clinical practice, policy and research advancements.
Annual meeting bringing together healthcare professionals, scientists, advocates, industry representatives, and others who are working toward better outcomes for people with epilepsy.
Europe's premier meeting in applied and translational neuroscience discussing the latest developments in research, technologies and treatment of brain disorders.
Annual mental health conference bringing together psychiatrists, nurse practitioners, physician assistants, psychologists, and other mental health professionals offering practical knowledge to improve patient care.
Meeting with a diverse group of stakeholders at the intersection of health care and policy to share important findings and latest research on how the health system works, what it costs, and how to improve it.
A national conference offering exclusive continuing education, legislative policy updates, hands-on workshops, lively exhibitors, and networking opportunities for the nurse practitioner community.
Annual meeting bringing perspectives together from academia, NIH, FDA, clinicians and industry on key aspects of neuropsychiatric drug development, pharmacogenetics and personalized interventions.
Annual congress offering scientific programs ranging from basic clinical sciences, psychiatric epidemiology, pharmacological and psychotherapies, to new digital technologies and understandings from related sciences such as anthropology, psychology and sociology.
Annual meeting attracting the largest audience of psychiatrists and other mental health professionals offering opportunities to learn the latest in effective clinical practice, policy and research advancements.
Global annual congress offering a platform for learning about the latest research advances and new treatments in neuropharmacology, psychiatry, and neuroscience.
Annual meeting in neurology promoting high quality patient-centric care in a variety of topics and specialties through various learning formats.
Annual congress to learn about new clinical tools, expand research frontiers, and explore innovative ideas for mental health care and prevention with a community of global professionals and stakeholders in psychiatry.